|
Volumn 30, Issue 5, 2000, Pages 757-761
|
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: Case-control and historical cohort studies
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
FOSCARNET;
GANCICLOVIR;
ADULT;
AIDS RELATED COMPLEX;
ANTIVIRAL ACTIVITY;
ARTICLE;
CANCER RISK;
CONTROLLED STUDY;
DOSE RESPONSE;
EPSTEIN BARR VIRUS;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
MALE;
NONHODGKIN LYMPHOMA;
PREVALENCE;
PRIORITY JOURNAL;
PROPHYLAXIS;
TREATMENT OUTCOME;
ACYCLOVIR;
ADULT;
ANTIVIRAL AGENTS;
CASE-CONTROL STUDIES;
COHORT STUDIES;
DRUG THERAPY, COMBINATION;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
FOSCARNET;
GANCICLOVIR;
HUMAN;
LYMPHOMA, AIDS-RELATED;
MALE;
MIDDLE AGE;
TIME FACTORS;
|
EID: 0033802467
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/313761 Document Type: Article |
Times cited : (29)
|
References (24)
|